{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:49:19Z","timestamp":1770900559420,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3683,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1111\/j.0022-202x.2005.23864.x","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T18:20:05Z","timestamp":1374862805000},"page":"936-944","source":"Crossref","is-referenced-by-count":70,"title":["Increased Sensitivity to Interferon-\u03b1 in Psoriatic T Cells"],"prefix":"10.1016","volume":"125","author":[{"given":"Karsten Wessel","family":"Eriksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Lovato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorbj\u00f8rn","family":"Krejsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keld","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0015","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1523-1747.ep12484908","article-title":"UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions","volume":"95","author":"Baadsgaard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.1984.tb07309.x","article-title":"T-cell subpopulations in the blood and skin of patients with psoriasis","volume":"110","author":"Baker","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ijc.2910200405","article-title":"Growth inhibitory effects of interferon on normal and malignant human haemopoietic cells","volume":"20","author":"Balkwill","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.1999.00622.x","article-title":"Cytokines in psoriasis","volume":"38","author":"Bonifati","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1189\/jlb.71.4.565","article-title":"Interferon-alpha as an immunotherapeutic protein","volume":"71","author":"Brassard","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0045","first-page":"211","article-title":"Practical management of patients treated with alpha interferon","volume":"60","author":"Brenard","year":"1997","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.leu.2403610","article-title":"Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha","volume":"19","author":"Brender","year":"2005","journal-title":"Leukemia"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0055","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","article-title":"Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells","volume":"178","author":"Brinkmann","year":"1993","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0060","first-page":"248","article-title":"Secondary hyperparathyroidism exacerbation: A rare side-effect of interferon-alpha?","volume":"51","author":"Calvino","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer-T cells in psoriasis","volume":"294","author":"Cameron","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0070","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","article-title":"Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy","volume":"65","author":"Conlon","year":"1990","journal-title":"Cancer"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0075","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/MCB.15.12.7050","article-title":"Differential regulation of the alpha\/beta interferon-stimulated Jak\/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1","volume":"15","author":"David","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.leu.2402093","article-title":"Constitutive STAT3-activation in Sezary syndrome: Tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells","volume":"15","author":"Eriksen","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1074\/jbc.M310472200","article-title":"Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells","volume":"279","author":"Eriksen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000018447","article-title":"Psoriasis associated with HCV and exacerbated by interferon alpha: Complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis","volume":"201","author":"Erkek","year":"2000","journal-title":"Dermatology"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1990.01670270083013","article-title":"Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations","volume":"126","author":"Fierlbeck","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004030000167","article-title":"Flow cytometric characterization of lesional T cells in psoriasis: Intracellular cytokine and surface antigen expression indicates an activated, memory\/effector type 1 immunophenotype","volume":"292","author":"Friedrich","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1523-1747.ep12335758","article-title":"T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice","volume":"109","author":"Gilhar","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/10799900360708632","article-title":"IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells","volume":"23","author":"Hibbert","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha\/beta signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0130","first-page":"161","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"Cell Dev Biol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0165-4608(95)00118-2","article-title":"Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines","volume":"85","author":"Kaltoft","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0733-8635(18)30176-1","article-title":"Cytogenetic findings in cell lines from cutaneous T-cell lymphoma","volume":"12","author":"Kaltoft","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.0906-6705.2004.00195.x","article-title":"Correlation of psoriasis activity with abundance of CD25+CD8+ T cells: Conditions for cloning T cells from psoriatic plaques","volume":"13","author":"Kohlmann","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0160","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/sj.onc.1203524","article-title":"Jak\u2013Stat signal transduction pathway through the eyes of cytokine class II receptor complexes","volume":"19","author":"Kotenko","year":"2000","journal-title":"Oncogene"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","article-title":"Psoriasis vulgaris: Cutaneous lymphoid tissue supports T-cell activation and \u2018Type 1\u2019 inflammatory gene expression","volume":"25","author":"Lew","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80413-6","article-title":"IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses","volume":"4","author":"Magram","year":"1996","journal-title":"Immunity"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1523-1747.ep12470545","article-title":"Binding of 125I-gamma interferon to cultured human keratinocytes","volume":"89","author":"Nickoloff","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(00)00120-1","article-title":"Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system","volume":"24","author":"Nickoloff","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0185","first-page":"23","article-title":"MHC class II molecules regulate growth in human T cells","volume":"11","author":"Nielsen","year":"1994","journal-title":"Exp Clin Immunogenet"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0190","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1399-0039.1998.tb03083.x","article-title":"Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines","volume":"52","author":"Nielsen","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0195","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4049\/jimmunol.125.4.1839","article-title":"Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity","volume":"125","author":"Ortaldo","year":"1980","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0200","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/eji.1830260328","article-title":"Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells","volume":"26","author":"Parronchi","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2340\/0001555573395","article-title":"Psoriasis exacerbation induced by interferon-alpha. Report of two cases","volume":"73","author":"Pauluzzi","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0210","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.4049\/jimmunol.161.12.6567","article-title":"The role of Stat4 in species-specific regulation of Th cell development by type I IFNs","volume":"161","author":"Rogge","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0220","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.165.4.1933","article-title":"IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells","volume":"165","author":"Sareneva","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0225","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.4049\/jimmunol.160.12.6032","article-title":"Influenza A virus-induced IFN-alpha\/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells","volume":"160","author":"Sareneva","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0235","first-page":"675","article-title":"Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes","volume":"150","author":"Skov","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0240","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1523-1747.ep12371678","article-title":"T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation","volume":"101","author":"Strange","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0250","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: Localization to both CD4+ and CD8+ subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0255","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0260","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0270","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM197210122871504","article-title":"Disturbance of HL-A antigen frequency in psoriasis","volume":"287","author":"White","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0275","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0280","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.273.5276.794","article-title":"Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain [see comments]","volume":"273","author":"Xu","year":"1996","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2005.23864.x_bb0285","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555575482483","article-title":"Psoriasis and hepatitis C virus","volume":"75","author":"Yamamoto","year":"1995","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T12:20:49Z","timestamp":1715775649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15325288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0022202X15325288"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23864.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}